van Schayck et al., 1995 - Google Patents
The influence of an inhaled steroid on quality of life in patients with asthma or COPDvan Schayck et al., 1995
View PDF- Document ID
- 4549674390587693728
- Author
- van Schayck C
- Dompeling E
- Rutten M
- Folgering H
- van den Boom G
- van Weel C
- Publication year
- Publication venue
- Chest
External Links
Snippet
Relatively little is known about the influence of inhaled corticosteroids on general well-being (quality of life) in patients with asthma or COPD. In a 4-year prospective controlled study, we examined the influence of beclomethasone dipropionate (BDP), 400 μg, two times daily, on …
- 208000006673 Asthma 0 title abstract description 84
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
- A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radiowaves
- A61B5/053—Measuring electrical impedance or conductance of a portion of the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
- A61B5/08—Detecting, measuring or recording devices for evaluating the respiratory organs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
- A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
- A61B5/411—Detecting or monitoring allergy or intolerance reactions to an allergenic agent or substance
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| van Schayck et al. | The influence of an inhaled steroid on quality of life in patients with asthma or COPD | |
| Kharitonov et al. | Changes in the dose of inhaled steroid affect exhaled nitric oxide levels in asthmatic patients | |
| Lessard et al. | Obesity and asthma: a specific phenotype? | |
| Farah et al. | Obesity is a determinant of asthma control independent of inflammation and lung mechanics | |
| Martin et al. | The predicting response to inhaled corticosteroid efficacy (PRICE) trial | |
| Sippel et al. | Exhaled nitric oxide levels correlate with measures of disease control in asthma | |
| Martínez-García et al. | Factors associated with lung function decline in adult patients with stable non-cystic fibrosis bronchiectasis | |
| Pauwels et al. | Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking | |
| Covar et al. | Safety and application of induced sputum analysis in childhood asthma | |
| Phillips et al. | Sleep-disordered breathing in healthy, aged persons: fifth and final year follow-up | |
| HajGhanbari et al. | Pain in people with chronic obstructive pulmonary disease (COPD) | |
| Moore et al. | Characterization of the severe asthma phenotype by the national heart, lung, and blood institute's severe asthma research program | |
| Brindicci et al. | Differential flow analysis of exhaled nitric oxide in patients with asthma of differing severity | |
| van Huisstede et al. | Underdiagnosis and overdiagnosis of asthma in the morbidly obese | |
| Nolte et al. | Dose-dependent anti-inflammatory effect of inhaled mometasone furoate/formoterol in subjects with asthma | |
| Fenger et al. | The longitudinal relationship of changes of adiposity to changes in pulmonary function and risk of asthma in a general adult population | |
| Lehmann et al. | Factors determining performance of bronchodilator reversibility tests in middle-aged and elderly | |
| Gelb et al. | In moderate-to-severe asthma patients monitoring exhaled nitric oxide during exacerbation is not a good predictor of spirometric response to oral corticosteroid | |
| Clearie et al. | Supervised step-down of inhaled corticosteroids in the community–an observational study | |
| Gill et al. | Exhaled nitric oxide levels during acute asthma exacerbation | |
| Juniper et al. | Health-related quality of life in moderate asthma: 400 μg hydrofluoroalkane beclomethasone dipropionate vs 800 μg chlorofluorocarbon beclomethasone dipropionate | |
| Prieto et al. | Airway responsiveness to adenosine 5′-monophosphate and exhaled nitric oxide measurements: predictive value as markers for reducing the dose of inhaled corticosteroids in asthmatic subjects | |
| Kelly et al. | Eosinophilic bronchitis in asthma: a model for establishing dose-response and relative potency of inhaled corticosteroids | |
| Kermode et al. | The effect of airway remodelling on airway hyper-responsiveness in asthma | |
| Bergström et al. | Adolescents with asthma: consequences of transition from paediatric to adult healthcare |